Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Clinical trials report

Clinical trials report Jerry W. Swanson, MD Effectiveness of Zolmitriptan Nasal Spray for the Acute Treatment of Cluster Headache: Study 1 Cittadini E, May A, Straube A, et al.: Effectiveness Aims: To evaluate ZNS in the acute treatment of of intranasal zolmitriptan in acute cluster headache: cluster headache. a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006, 63:1537–1542. Methods: Ninety-two patients (80 men and 12 women) 40 ± 10 years of age (mean ± SD) with International Rating: •Of importance. Headache Society–defined cluster headache were randomized into a placebo-controlled, double-blind Introduction: Cluster headache is a primary headache dis- crossover study. Patients treated three headache attacks order that is relatively uncommon in the general population using placebo for one attack, 5 mg of ZNS for one but is seen frequently in neurologic, and especially head- attack, and 10 mg of ZNS for one attack. The primary ache, specialty practices. It is the prototype of the group of end point was headache relief at 30 minutes, defined as disorders collectively known as the trigeminal autonomic reduction from moderate, severe, or very severe pain to cephalalgias. As succinctly described in the International no or mild pain. Classification of Headache Disorders [1], cluster headache is characterized http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Neurology and Neuroscience Reports Springer Journals

Clinical trials report

Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/clinical-trials-report-oZuruIM5la

References (2)

Publisher
Springer Journals
Copyright
Copyright © 2008 by Current Medicine Group LLC
Subject
Medicine & Public Health; Neurology
ISSN
1528-4042
eISSN
1534-6293
DOI
10.1007/s11910-008-0014-1
Publisher site
See Article on Publisher Site

Abstract

Jerry W. Swanson, MD Effectiveness of Zolmitriptan Nasal Spray for the Acute Treatment of Cluster Headache: Study 1 Cittadini E, May A, Straube A, et al.: Effectiveness Aims: To evaluate ZNS in the acute treatment of of intranasal zolmitriptan in acute cluster headache: cluster headache. a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006, 63:1537–1542. Methods: Ninety-two patients (80 men and 12 women) 40 ± 10 years of age (mean ± SD) with International Rating: •Of importance. Headache Society–defined cluster headache were randomized into a placebo-controlled, double-blind Introduction: Cluster headache is a primary headache dis- crossover study. Patients treated three headache attacks order that is relatively uncommon in the general population using placebo for one attack, 5 mg of ZNS for one but is seen frequently in neurologic, and especially head- attack, and 10 mg of ZNS for one attack. The primary ache, specialty practices. It is the prototype of the group of end point was headache relief at 30 minutes, defined as disorders collectively known as the trigeminal autonomic reduction from moderate, severe, or very severe pain to cephalalgias. As succinctly described in the International no or mild pain. Classification of Headache Disorders [1], cluster headache is characterized

Journal

Current Neurology and Neuroscience Reports – Springer Journals

Published: Mar 29, 2008

There are no references for this article.